Detox is the part of treatment where the medical infrastructure question matters most directly. Alcohol withdrawal is one of the few withdrawal syndromes that can become medically dangerous without proper supervision: according to clinical literature on alcohol withdrawal syndrome, untreated delirium tremens has a historical mortality rate as high as 37%, and roughly 3 to 5% of people withdrawing from alcohol develop severe symptoms, including seizures and delirium.
Benzodiazepines Carry a Related Risk
Benzodiazepine withdrawal carries a related risk. Clinical guidance on benzodiazepine management is unambiguous that abrupt discontinuation after regular use can trigger seizures, and that anyone who has taken benzodiazepines regularly for more than a few weeks should never stop abruptly — a gradual, supervised taper is the standard of care.
What Medical Supervision Actually Involves
"Medically supervised" is sometimes used loosely in marketing, so it is worth being specific about what it means in practice. A properly supervised detox involves a physician-directed intake assessment that reviews substance history, dosage, duration of use, prior withdrawal episodes and current medications; ongoing vital-sign monitoring, since blood pressure, heart rate and temperature changes are early warning signs in both alcohol and benzodiazepine withdrawal; a validated withdrawal-severity scale, used repeatedly rather than once, so that escalating symptoms are caught early rather than after a crisis point; and a physician with the authority to adjust medication doses in real time rather than following a fixed schedule regardless of how a person is responding. Any one of those elements missing changes the risk profile of the process.
Why the Timeline Matters
Withdrawal risk is not constant across the process — it has a shape. Alcohol withdrawal symptoms typically begin within hours of the last drink, and the highest-risk window for seizures and delirium tremens generally falls within the first several days. Benzodiazepine withdrawal timing depends heavily on the specific medication's half-life: shorter-acting compounds tend to produce an earlier, sharper withdrawal course, while longer-acting compounds can produce a slower, more protracted one. That variability is exactly why a fixed, one-size-fits-all taper schedule is inadequate — the pacing needs to be set and adjusted by a physician who is actively monitoring the individual, not read off a generic chart. For a closer look at how this unfolds hour by hour, see our alcohol detox timeline and our overview of the benzodiazepine kindling effect, which explains why repeated unsupervised withdrawal attempts tend to make each subsequent withdrawal riskier.
Polysubstance Use Raises the Stakes
Many people entering detox are not withdrawing from a single substance. Concurrent alcohol and benzodiazepine dependence is common, and each compounds the risk profile of the other because both act on the same GABAergic system; withdrawing from both simultaneously without a coordinated medical plan is considerably more dangerous than withdrawing from either alone. Opioid, stimulant or polydrug histories add further variables — different timelines, different symptom patterns, and different medication protocols — that a generic detox setting is not equipped to individualize. This is one of the clearest arguments for a licensed medical team rather than a peer-support or non-medical residential setting: the assessment has to account for the full substance history, not just the substance a person names first.
What Happens After Stabilization
Medical detox addresses acute physical withdrawal risk; it is the beginning of treatment, not the whole of it. Once a person is medically stable, the clinical work shifts toward the underlying drivers of substance use — the psychological, relational and physiological patterns that made active use feel necessary in the first place. At Sanctuary Tulum, that transition is built into the structure of the program: physician-supervised detox leads directly into the therapeutic and integrative framework described on our Pouyan Method™ page, rather than treating detox as a stand-alone service disconnected from what comes next.
Questions Worth Asking Before Choosing a Program
A short list of direct questions tends to separate genuinely medical detox programs from settings that describe themselves that way for marketing purposes: Is a physician on-site or on-call around the clock, and how quickly can they respond? What withdrawal-severity scale is used, and how often is it administered? What is the protocol if symptoms escalate outside expected parameters — is there a relationship with a hospital capable of a higher level of care? Are medications adjusted individually, or dispensed on a fixed schedule regardless of presentation? A program that answers those questions specifically and confidently is describing an actual clinical process; one that answers only in terms of comfort and amenities is describing something else.
What the Setting Does and Doesn't Do
A luxury setting doesn't change any of this; a licensed medical team monitoring the process directly does. The value of a well-run luxury detox program is combining that direct medical oversight with the privacy and individualized pacing a standard detox unit typically can't offer.
For benzodiazepine-specific withdrawal, our luxury benzo detox page details the added precautions we take; the general process is covered on our medically supervised luxury detox page.
